Phase II trial of weekly 1-hour taxol and herceptin for metastatic breast cancer: Toward further exploitation of proven synergistic antitumor activity Meeting Abstract


Authors: Seidman, A. D.; Fornier, M.; Hudis, C.; Theodoulou, M.; Surbone, A.; Moynahan, M. E.; Currie, V.; Moasser, M.; Chin, J.; Bach, A.; Denton, C.; Rosen, P.; Norton, L.
Abstract Title: Phase II trial of weekly 1-hour taxol and herceptin for metastatic breast cancer: Toward further exploitation of proven synergistic antitumor activity
Meeting Title: 16th Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow
Keywords: meeting abstract
Journal Title: Cancer Investigation
Volume: 17
Issue: Suppl. 1
Meeting Dates: 1998 Nov 11-13
Meeting Location: New York, NY
ISSN: 0735-7907
Publisher: Informa Healthcare  
Date Published: 1999-01-01
Start Page: 44
End Page: 45
Language: English
ACCESSION: BCI:BCI199900163193
PROVIDER: biosis
PUBMED: 10083854
Notes: Meeting abstract: 37 -- Chemotherapy Foundation -- Source: Biosis
Citation Impact
MSK Authors
  1. Mark M Moasser
    56 Moasser
  2. Andrew D Seidman
    318 Seidman
  3. Mary Ellen Moynahan
    105 Moynahan
  4. Clifford Hudis
    905 Hudis
  5. Larry Norton
    758 Norton
  6. Ariadne Bach
    59 Bach
  7. Monica Nancy Fornier
    158 Fornier
  8. Violante Currie
    51 Currie
  9. Paul P Rosen
    201 Rosen
  10. Chirly Denton
    2 Denton
  11. Antonella   Surbone
    33 Surbone